Significant Ownership of Datuk Dr. Doris Wong Sing Ee
- Signature - Title
- /s/ Datuk Dr. Doris Wong Sing Ee - Chief Executive Officer and Executive Director
- Location
- Wilayahpersekutuankuala Lumpur, Malaysia
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Datuk Dr. Doris Wong Sing Ee.
Follow Filing Activity
Follow Datuk Dr. Doris Wong Sing Ee and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Datuk Dr. Doris Wong Sing Ee
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 70% | $58,388,646 | 194,628,820 | Doris Wong Sing Ee | 26 Feb 2025 | ||
| BGMS | Bio Green Med Solution, Inc. | Common Stock, par value $0.0001 per share | 21% | $5,555,655 | 1,111,131 | Doris Wong Sing Ee | 12 Nov 2025 |
Schedules 13D/G Reported by Datuk Dr. Doris Wong Sing Ee:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.